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Circadian rhythm disruptions are prominently associated with bipolar disorder (BD). 
Circadian rhythms are regulated by the molecular clock, a family of proteins that function 
together in a transcriptional–translational feedback loop. The CLOCK protein is a key tran-
scription factor of this feedback loop, and previous studies have found that manipulations 
of the Clock gene are sufficient to produce manic-like behavior in mice (1). The CLOCK 
3111T/C single-nucleotide polymorphism (SNP; rs1801260) is a genetic variation of the 
human CLOCK gene that is significantly associated with increased frequency of manic 
episodes in BD patients (2). The 3111T/C SNP is located in the 3′-untranslated region of 
the CLOCK gene. In this study, we sought to examine the functional implications of the 
human CLOCK 3111T/C SNP by transfecting a mammalian cell line (mouse embryonic 
fibroblasts isolated from Clock −/− knockout mice) with pcDNA plasmids containing the 
human CLOCK gene with either the T or C SNP at position 3111. We then measured 
circadian gene expression over a 24-h time period. We found that the CLOCK3111C 
SNP resulted in higher mRNA levels than the CLOCK 3111T SNP. Furthermore, we 
found that Per2, a transcriptional target of CLOCK, was also more highly expressed 
with CLOCK 3111C expression, indicating that the 3′-UTR SNP affects the expression, 
function, and stability of CLOCK mRNA.
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inTrODUcTiOn
Bipolar disorder (BD) is a severe and chronic psychiatric disease that afflicts approximately 1–3% 
of the United States population (3). BD incurs substantial societal burdens, including a devastating 
global cost of illness primarily due to patients’ lower level of functioning, greater severity of disability, 
longer duration of illness, and ultimately greater loss in productivity when compared patients with 
other mood disorders (4, 5). BD therapies currently in use include mood stabilizers, such as lithium 
and valproate; however, these are effective for only a portion of patients (6). The underlying cause of 
BD is unknown, though there is a growing body of evidence linking disruptions in circadian rhythms 
with the disease (7).
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Disruption of sleep and circadian rhythms are common to 
many psychiatric disorders, including BD, which presents with 
severe circadian rhythm disruptions as a prominent symptom. It 
has been shown that in individuals with BD, mood episodes are 
affected by light and also follow seasonal patterns (6, 8–10). In 
addition to fluctuations in mood, BD patients typically exhibit 
irregularities in important physiological processes that are largely 
regulated by the body’s circadian rhythms (such as sleep, diurnal 
activity, body temperature, and blood pressure cycles). Mood 
stabilizers, such as lithium, are known to restore some of these 
disrupted rhythms in BD patients by producing a strong phase-
delay in rhythms and increasing rhythmic amplitude, which may 
be very important for their observed therapeutic effects (11–17).
Circadian rhythms are regulated by a molecular clock, which 
consists of several core “clock” genes (e.g., Clock, Npas2, Bmal1, 
Per1, and Per2) that are expressed throughout the body. These 
elements interact with each other through a series of transcrip-
tional and translational feedback loops that are regulated over a 
24-h period in the absence of environmental input (18). Within 
the suprachiasmatic nucleus (SCN) and other regions, circadian 
rhythms are controlled by the molecular clockwork, which 
comprises a series of autoregulatory transcriptional–translational 
feedback loops. The transcription factors CLOCK or NPAS2 het-
erodimerize with BMAL1 and regulate the transcription of target 
genes, including the Period (Per) and Cryptochrome (Cry) genes, 
which act to inhibit the activity of the CLOCK/BMAL1 complex. 
Several pre-clinical studies have identified an important role 
for circadian genes in mood-related behaviors. Recent human 
genetic studies have linked elements of the molecular clock to 
BD. Polymorphisms in CLOCK and other circadian genes have 
been found to be associated with various aspects of BD (19–25). 
In addition, rhythm disruptions and sleep disturbances often pre-
cipitate manic or depressive episodes (26). By studying molecular 
mechanisms that may underlie such BD symptoms, we can gain 
a better understanding of its causes and how to most effectively 
treat patients with this crippling disease.
The importance of circadian genes in BD has been suggested 
by several human genetic studies that have identified significant 
associations between mutations or polymorphisms of circadian 
genes and BD. The Per genes, which act as key repressors of the 
circadian transcriptional–translational feedback loop in humans, 
have been found to associate with mood disorders and their age of 
onset (27, 28). Recent genome-wide association studies (GWAS) 
have also implicated circadian modulators, such as ARNTL and 
DEC1, as significantly associated with BD (29). These results are 
particularly important given that data from family and twin stud-
ies that have established BD’s genetic heritability as up to 85%, 
suggesting a strong genetic component (30). Here, we investigate 
the role of a single-nucleotide polymorphism (SNP) in one 
circadian gene, CLOCK, that has been associated with BD (2). 
Interestingly, the CLOCK 3111T/C SNP is a genetic variant of the 
human CLOCK gene that has been associated with bipolar mania 
in BD patients. Specifically, this T→C polymorphism (rs1801260) 
associates with increased actimetric and sleep disturbances and 
incidences of manic episodes in bipolar patients (2, 31, 32). The 
prevalence of the 3111C has been reported to be between 19 
and 21% in American populations (33). BD patients carrying 
the 3111C allele experience higher rates of insomnia and sleep 
disturbances, and differences between the 3111C and 3111T allele 
carriers were attenuated with ongoing chronic lithium treatment 
(32). No research group, however, has yet sought to determine the 
molecular mechanism through which this SNP can affect indi-
viduals with BD. The 3111T/C SNP is located within the CLOCK 
gene’s 3′-untranslated region (3′-UTR). The 3′-UTR is a region 
that has been shown to be very important for mRNA stability and 
modifications to this region can lead to either increased stability 
or degradation of gene products (34, 35).
Moreover, preclinical studies have shown that manipulations 
of the circadian gene, Clock, are sufficient to produce a behavioral 
phenotype sharing several features with bipolar mania. Mice with a 
dominant-negative Clock gene mutation exhibit a manic-like phe-
notype, including hyperactivity, reduced anxiety and depression-
like behaviors, and increased drug and alcohol intake (1, 36–38). 
Similar to human BD patients, these mutant mice are responsive to 
chronic lithium, as well as valproate  treatment (39, 40).
Together, these results have led us to hypothesize that the 
3111C SNP in the CLOCK gene decreases Clock mRNA and/
or protein levels, and that this could be a possible mechanism 
through which this polymorphism can affect mood in individuals 
with BD. In this study, we investigated the effects of the human 
3111T/C SNP on CLOCK mRNA in a mammalian cell line by 
examining the differences between the 3111T and 3111C variants 
of CLOCK.
MaTerials anD MeThODs
Plasmid construction
The pBluescript II plasmid containing the full human CLOCK 
gene (product i.d. ORK00509, Kazusa), was digested with Apa1 
and Not1 restriction enzymes. The DNA fragment containing 
the CLOCK gene was isolated using agarose gel electrophoresis 
and the QIAQuick gel purification kit (catalog no. 28704, 
QIAGEN). The 5kb CLOCK containing fragment was ligated 
into the pcDNA3.1(−) plasmid (catalog no. V795-20, Invitrogen) 
digested with Apa1 and Not1 restriction enzyme sites (5′ end and 
3′ end, respectively) and treated with calf intestinal phosphatase 
to prevent self-ligation. The ligated plasmids were transformed 
into One-Shot TOP10 Chemically Competent Escherichia coli 
cells (catalog no. C4040-10, Invitrogen). We performed site-
directed mutagenesis of the CLOCK construct at the site of the 
3111T/C SNP using the Quikchange II XL Site-Directed Kit 
(catalog no. 200521, Agilent) to perform a C to T transforma-
tion, creating a 3111T version of the CLOCK gene 3′-UTR 
(forward primer: 5′-GAGGTGATCATAGGGGCATAGCCAG 
TTCTGACAGTG-3′, reverse primer: 5′-CACTGTCA GAACT 
GGCTATGCCCCTATGATCACCTC-3′). The full construct was 
verified through a series of restriction enzyme digests and com-
plete sequencing of the CLOCK gene (including cloning junctions) 
by the University of Pittsburgh Genomics and Proteomics Core 
Laboratories. Isolated and sequence-verified clones were grown 
in E. coli and plasmids were isolated using QIAGEN’s QIAprep 
Spin Miniprep kit (catalog no. 27104) and endonuclease-free 
Plasmid Maxi Kit (catalog no. 12162).
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shrna construction
A small hairpin RNA (shRNA) was constructed 
against the Npas2 gene by selecting a 24 base sequence 
(5′-GAACACTGGATTCTTCCTGTTAAC-3′) in the 3′-UTR 
(41). For the scrambled (Scr) shRNA, a random sequence 
of 24 bases (5′-CGGAATTTAGTTACGGGGATCCAC-3′) 
that had no sequence similarities with any known genes/
mRNA was used (42). An anti-sense sequence of the selected 
mRNA region followed by a miR23 loop of 10 nucleotides 
(CTTCCTGTCA) was added at the 5′ end of the above 
sequences. The miR23 loop facilitates the transfer of the 
hairpin RNA out of the nucleus. These shRNAs were designed 
as synthetic duplexes with overhang ends identical to those 
created by SapI and XbaI restriction enzyme digestion. 
The annealed oligonucleotides were cloned into the adeno-
associated virus (AAV) plasmid expressing enhanced green 
fluorescent protein (GFP) (catalog no. 240075, Agilent 
Technologies).
Preparation of Mouse embryonic 
Fibroblasts
Mouse embryonic fibroblasts (MEFs) were isolated and 
prepared from homozygous Clock knockout (KO) mice at 
13–14 day post-coitum (Jackson Labs, Bar Harbor, ME, USA, 
stock#010925) (43). All experiments were approved by the 
Institutional Animal Care and Use Committee and adhered to 
NIH Guidelines. Clock KO MEFs were used to avoid confounds 
of endogenous Clock gene expression when measuring expres-
sion levels in MEFs transfected with the 3111T/C constructs. 
Briefly, uterine horns were dissected, and embryos were 
individually separated. The head and red organs were removed 
before the embryos were finely minced using a sterile razor 
blade. Minced tissue was treated with 0.05% Trypsin-EDTA 
(Gibco, Invitrogen) and DNase I (USB), and incubated for 
15 min at 37°C. Cells were centrifuged at 600 × g for 5 min, and 
supernatant was carefully removed before resuspending the 
MEF cell pellet in a warm solution of media containing high-
glucose Dulbecco’s modified Eagle medium (DMEM) with 
l-glutamine (catalog no. 11965-084, GIBCO), supplemented 
with 10% FBS (catalog no. 16000-044, GIBCO), 100  units/
ml penicillin, 100  units/ml streptomycin, and 1  mM sodium 
pyruvate (catalog no. 11360-070, GIBCO). MEFs were stored 
at −80°C.
cell culture and Plasmid Transfection
Mouse embryonic fibroblast cells were cultured at 37°C with 5% 
CO2 in high-glucose DMEM with l-glutamine, supplemented 
with 10% FBS, 100 units/ml penicillin, 100 units/ml streptomy-
cin, and 1 mM sodium pyruvate. Cells were grown to 80–100% 
confluence before being split using 0.25% Trypsin-EDTA 
with phenol red (catalog no. 25200-056, GIBCO). MEFs were 
transfected with plasmid construct(s) using Lipofectamine LTX 
(catalog no. 15338-100, Invitrogen) and Opti-MEM I Reduced 
Media Serum (catalog no. 31985-062, Invitrogen) according to 
the manufacturer’s instructions. Following transfections, cells 
were collected for RNA isolation and quantitative RT-PCR.
rna isolation and cDna synthesis
Approximately, 1 ×  105 cells were transfected with 2 μg of the 
3111T or 3111C versions of the CLOCK SNP. Seventy-two 
hours following transfection with expression constructs, cells 
were selected using 100  μg/ml Geneticin Selective Antibiotic 
(catalog no. 10131-035, GIBCO) to generate stable lines. After 
selection, RNA from the MEFs was isolated using TRIzol reagent 
(catalog no. 15596-026, Ambion), according to the manufac-
turer’s instructions. Briefly, cells were treated with TRIzol reagent 
and chloroform, and RNA was isolated with the addition of the 
carrier glycogen, followed by precipitation in isopropanol and 
centrifugation. Seventy-five percent ethanol was used to wash the 
RNA pellet, which was re-suspended in nuclease-free H2O. Total 
RNA (200 ng) was treated with DNase I (Catalog no. 18068-015, 
Invitrogen), and then reverse-transcribed to cDNA using the 
SuperScript III First-Strand Synthesis System (catalog no. 18080-
051, Invitrogen) according to manufacturer’s protocols.
Quantitative real-Time Pcr
Real-time quantitative polymerase chain reaction (RT-PCR) was 
completed using the 7900HT Fast Real-Time PCR System (catalog 
no. 4329003, Applied Biosystems). cDNA samples were prepared 
with the Power SYBR Green qPCR Master Mix (catalog no. 4367659, 
Applied Biosystems) along with oligo primers for hCLOCK 
(forward primer: 5′-ATGGGCCAGGTGGTGACTGCAT-3′, 
reverse primer: 5′-TGACCCAGCCACCGCAACAAT-3′), 
G418-resistance gene present in pcDNA3.1(−) (forward primer: 
5′-CGCATGATTGAACAAGATGGATTGC-3′, reverse primer: 
5′-GTTCATTCAGGGCACCGGACA-3′), and mPer2 (for-
ward primer 5′-GAGTGTGTGCAGCGGCTTAG-3′, reverse 
primer 5′-GTAGGGTGTCATGCGGAAGG-3′). PCRs were 
run in duplicate, followed by a dissociation reaction, and were 
subjected to agarose gel electrophoresis to determine specificity 
of the amplified product. Gene expression was quantified using 
the ΔCT (CT = cycle threshold) method as previously described 
(44). Gel electrophoresis of the samples was then performed in 
order to further confirm the correct size of the amplified PCR 
products. Efficiencies of qPCR primers used in this study were 
calculated by means of construction of a standard curve as previ-
ously described (45). Samples of experimental MEF cDNA were 
serially diluted and prepared with the Power SYBR Green qPCR 
Master Mix (catalog no. 4367659, Applied Biosystems). Dilution 
series from 1:1 to 1:64 were used for transfected genes (hCLOCK, 
G418-resistance gene), while dilution series from 1:1 to 1:8 were 
used for endogenous genes (mPer2, Npas2). qPCRs were run in 
duplicate and followed by a dissociation reaction. Gene expres-
sion was quantified using the ΔCT method and plotted against 
the logarithm of the dilution factor. The calculated efficiencies for 
the primer sets used are as follows: hClock 88%, G418 93%, mPer2 
110%, and Npas2 78%. The observed relatively low expression 
levels of Npas2 indicate that CLOCK KO MEFs do not express 
high levels of Npas2 to compensate for the loss of CLOCK. The 
hCLOCK and G418 primer sets used for determination and com-
parison of CLOCK3111T and CLOCK3111C levels have similar 
efficiencies; therefore, we conclude that these findings do not 
affect interpretation of the data.
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circadian gene expression assay
Approximately 1  ×  104 cells were plated in 12-well plates, 
and were doubly transfected with 1 μg each of pcDNA3.1(−) 
(containing the 3111T, 3111C, or no insert), and a plasmid 
containing Npas2 shRNA or a Scr shRNA. A caveat of using 
Clock KO MEFs was that previous research has shown that KO 
of the Clock gene can result in increased Npas2 expression, pos-
sibly as a compensatory mechanism (46). Because, as a CLOCK 
homolog, NPAS2 also regulates Per2 gene expression, an Npas2 
shRNA was co-transfected along with either versions of the 
3111T/C SNP when measuring Per2 circadian gene expression 
in qPCR studies. Seventy-two hours following transfection, 
MEFs were subjected to serum shock to synchronize individual 
molecular rhythms as previously described (47). Briefly, cells 
were serum shocked using DMEM supplemented with 50% 
horse serum for 30  min to induce expression of circadian 
genes and synchronize the molecular clock (48). After the 
serum shock treatment, MEFs were switched to recovery 
media containing high-glucose DMEM with l-glutamine 
supplemented with 2% B-27 (catalog no. 17504-044, GIBCO), 
350 mg/l sodium bicarbonate, 0.25% penicillin/streptomycin, 
and 10  mM HEPES (catalog no. 15630-106, GIBCO). Cells 
were collected every 3 h for the next 27 h (e.g., circadian time 
CT3, CT6, CT9, CT12, etc.) and processed for RNA isolation/
cDNA synthesis. Samples were then used to measure circadian 
gene expression (as described in Section “Quantitative Real-
Time PCR”).
statistics
All data are presented as the mean ± SEM. Two-way analysis 
of variance (ANOVA) and Student’s t-tests were performed 
to determine significant differences between experimental 
groups and time points. Statistical outliers were identified 
as ±2× SD of the mean and removed prior to further data 
analysis.
resUlTs
Npas2 gene expression in MeF cells and 
Knock-Down
NPAS2, a homolog of CLOCK, can heterodimerize with 
BMAL1 and positively regulate the transcription of Per and 
Cry genes. Since it is possible that Npas2 may be upregulated in 
Clock KO MEFs, Npas2 expression in WT and Clock KO MEFs 
was measured using qPCR (Figure  1A). After normalizing 
CT values to GAPDH, we performed a two-tailed unpaired 
Student’s t-test on our preliminary data, which revealed a 
statistically significant difference between mean ΔCT values 
[n = 2, Figure 1A]. These data show a 4.59-cycle increase in 
Npas2 expression in Clock KO MEFs compared to WT MEFs 
(Student’s t-test, P < 0.05). We used an shRNA to knockdown 
expression of Npas2. Npas2 shRNA resulted in a decrease in 
Npas2 expression as compared with Scr shRNA, as qPCR 
studies revealed that Npas2 gene expression was undetected 
after 40 cycles of PCR in cells expressing the Npas2 shRNA. 
Representative data from ZT21 is shown (Figure 1B).
clOcK 3111T/c snP gene expression 
(single Time Point)
To better understand the effects of the CLOCK 3111T/C SNP on 
mRNA expression and stability, we transfected Clock KO MEFs 
with either version of the SNP and sought to measure differences 
in CLOCK mRNA levels between cells expressing the 3111C 
and 3111T alleles (at a single time point). Using primers for the 
human CLOCK gene, our studies revealed that cells expressing 
the 3111C allele showed a 4.17-fold increase in CLOCK mRNA 
levels (Student’s t-test, P < 0.05, n = 8, Figure 2). Transfection 
efficiency was not directly evaluated; we used antibiotic selection 
to ensure proliferation of only transfected cells. Furthermore, 
we used the housekeeping gene, G418 (the gene in the pcDNA 
plasmid that is responsible for conferring antibiotic resistance to 
Geneticin) for calculating the dCT.
Twenty-Four-hour gene expression levels 
of CLOCK 3111T/c and Per2
To test the functional implications of the CLOCK 3111T/C SNP 
on CLOCK mRNA expression and stability over a 24-h time 
period, we transfected CLOCK KO MEFs with either version 
of the SNP and sought to determine if there were differences in 
CLOCK mRNA levels between cells expressing the 3111C and 
3111T alleles. Transfection efficiency was not directly evaluated; 
we used the housekeeping gene, G418 (the gene in the pcDNA 
plasmid that is responsible for conferring antibiotic resistance 
to geneticin) for calculating the dCT. Our findings show that 
MEFs transfected with the 3111C construct showed significantly 
increased levels of CLOCK mRNA at every time point measured, 
excluding CT18 (n = 4/group/timepoint, Figure 3). Using a two-
way ANOVA, we found a highly significant SNP × time interac-
tion; SNP ×  time [F =  (21, 93) = 5.34, P < 0.0001]. The main 
effect of the SNP was highly significant; [F =  (3, 93) = 156.45, 
P < 0.0001], as was the main effect of time; [F = (7, 93) = 16.68, 
P <  0.0001]. Bonferroni post  hoc test results reveal significant 
differences in CLOCK expression in MEFs co-transfected with 
3111T or C SNP constructs (along with Npas2 shRNA; Figure 3). 
We were primarily interested in these group comparisons (due to 
the upregulation of Npas2 in Clock KO MEFs). There were no sig-
nificant differences in CLOCK expression seen in cells transfected 
with or without the Npas2 shRNA.
To test the CLOCK 3111T/C SNP’s effects on CLOCK protein 
function, 24-h Per2 expression was measured in Clock KO MEFs 
co-transfected with the 3111T or 3111C constructs and the Npas2 
shRNA (n = 4/group/timepoint, Figure 4). As a downstream tran-
scriptional target of the CLOCK protein, Per2 is expressed as part 
of a transcriptional–translational feedback loop in the molecular 
clock. Therefore, alterations to Per2 expression indirectly reveal 
differences in CLOCK’s transcriptional activity between cells 
expressing the T or C variant of the SNP. Npas2 shRNA plasmid 
was co-transfected along with the human CLOCK constructs 
in order to eliminate the possible confound of Per2 expression 
driven by NPAS2. Using a two-way ANOVA, we found a sig-
nificant interaction between SNP and time: SNP × time [F = (21, 
95) = 8.52, P < 0.0001]. We also found that the main effect of the 
SNP was highly significant; [F = (3, 95) = 523.66, P < 0.0001]. 
FigUre 3 | Twenty-four-hour expression of hCLOCK in 3111T/c 
snP-expressing MeFs. Clock 3111C gene expression over 24 h is 
significantly higher than Clock 3111T expression. ****P < 0.0001, 
***P < 0.001, **P < 0.01, *P < 0.05.
FigUre 2 | Fold change difference in hCLOCK levels in 
Clock3111T/c-expressing MeFs (single time point). Clock 3111C gene 
expression is significantly higher than 3111T expression. *P < 0.05.
FigUre 1 | Npas2 expression in clock KO and WT MeFs. (a) Npas2 expression is significantly increased in Clock KO MEFS. *P < 0.05. (B) Npas2 shRNA 
results in significantly decreased Npas2 expression as compared with Scramble shRNA (representative data from CT21).
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The main effect of time was also significant; [F = (7, 95) = 23.67, 
P < 0.0001]. Bonferroni post hoc testing revealed that in MEFs 
expressing the CLOCK 3111C variant and Npas2 shRNA, expres-
sion of Per2 mRNA is significantly increased at every time point 
measured.
DiscUssiOn
Severe circadian rhythm disruptions are prominent symptoms 
in mood disorders, including BD and major depression. There 
is mounting pre-clinical and clinical data, suggesting that circa-
dian genes play a role in a number of disease parameters, such as 
age of onset (27, 28). Here, we sought to study the implications 
of the CLOCK 3111T/C SNP, a polymorphism located in the 3′-
UTR that has been shown to associate with increased frequency 
and severity of manic episodes and actimetric disturbances in 
BD patients (2, 31, 32). Alterations to the 3′-UTR have been 
shown to engage in transcriptional and translational regulation 
through various pathways, including those involving mRNA 
stability and degradation (49). In addition, previous animal 
research has found that reductions in CLOCK expression or 
function produces increased locomotor and drug- and alcohol-
seeking behavior, and decreased depression- and anxiety-like 
behavior  –  hallmarks of bipolar mania (1, 36–38). Therefore, 
we sought to test the hypothesis that the 3111C variant of the 
3111T/C SNP would result in reduced CLOCK expression and 
alter Per2 expression (as a measure of altered CLOCK tran-
scriptional activity) when compared to the 3111T allele. Using 
cell culture and qPCR, we found that the 3111C variant results 
in significantly increased CLOCK and Per2 mRNA expression 
over 24 h.
FigUre 4 | Twenty-four-hour expression of Per2 in 3111T/c 
snP-expressing MeFs. Clock3111C gene expression over 24 h is 
significantly higher than Clock3111T expression. ****P < 0.0001.
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These findings are very exciting as there is a clear dearth in the 
literature of molecular research of this SNP. The possibility that a 
clinically relevant SNP results in increased CLOCK expression is 
important to many interesting genes, including related circadian 
genes as well as those outside of the molecular clock. For example, 
in this study, we report that Per2, a gene positively regulated by 
CLOCK, exhibits significantly elevated expression over 24  h 
in cells expressing the CLOCK 3111C SNP. This suggests that 
CLOCK protein levels are also increased.
Changes in expression of these related circadian genes may 
have important implications for rhythms of critical physi-
ological processes. Sleep/wake, hormonal, body temperature, 
and blood pressure rhythms, for instance, are all influenced by 
molecular clockwork. These changes may also be important in 
the understanding and development of effective treatments for 
mood disorders, as current therapies have been shown to strongly 
phase-shift circadian rhythms. For example, selective serotonin 
reuptake inhibitors (SSRI’s) and morning-light therapy produce 
circadian phase shift advances in the SCN, while lithium and val-
proate induce phase shift delays and period-lengthening (50–54).
Outside of the molecular clock, changes in CLOCK expression may 
have tremendous implications for a wide variety of genes that clearly 
play an important role in regulating mood and behavior. Tyrosine 
hydroxylase (TH), dopamine receptor D3 (Drd3), cholecystokinin 
(CCK), and many other regulators of dopaminergic transmission 
are under transcriptional control by the CLOCK protein (46, 55, 
56). Additionally, mice with an induced mutation of the Clock gene, 
which results in overexpression of a truncated CLOCK protein with 
dominant-negative function, express a behavioral profile strongly 
resembling BD patients in the manic state that can be reversed using 
chronic lithium treatment (1). These mice show increased dopamine 
synthesis and dopamine firing in the ventral tegmental area (VTA), a 
region featuring important dopaminergic projections that have been 
implicated in psychiatric disorders (39). This includes an increase in 
TH expression in the VTA (36). Most of the manic-like behavioral 
phenotypes of these mutant mice are rescued with the induced expres-
sion of a functional CLOCK protein in the VTA, while knockdown 
of Clock expression in the VTA in wild-type mice produces a “mixed 
state” of reduced anxiety- but increased depression-like behavior (1, 
40, 42). Taking this into consideration, it becomes easy to see how 
a SNP affecting Clock expression can have major functional conse-
quences for a number of diseases.
It is still unclear as to how CLOCK mRNA levels are increased 
in cells expressing the 3111C variant. Changes in mRNA levels 
for 3111C could be due to increased stability of the mRNA. One 
possible mechanism to explain the increased mRNA stability is 
that the 3′-UTR hosts several regulatory elements controlling 
stability, one of which is binding sites for microRNAs (miRNAs). 
miRNAs are short, untranslated sequences of RNA that bind 
specific RNA sequences and, once bound, decrease mRNA 
transcript stability (57). The 3′-UTR of the CLOCK gene also 
features a binding site for miRNA-182 less than 40 bases from the 
3111T/C SNP that may affect stability of the mRNA by prevent-
ing or activating degradation mechanisms. It is possible that the 
3111C variant may interfere with this site, reducing miRNA-182 
binding and thereby increasing stability and elevating levels of 
CLOCK mRNA.
Our studies show that the CLOCK 3111T/C SNP has important 
functional consequences by increasing CLOCK and Per2 mRNA 
expression over 24 h. These changes may be due to a number of 
different mechanisms, including miRNA-182 binding sites in the 
3′-UTR. In the future, we plan to investigate whether miRNA-182 
binding is altered in the 3111T/C SNP. Additional future studies 
may focus on behavioral studies involving transgenic mice that 
express either version of the 3111T/C SNP. Given that our studies 
report altered Per2 expression, the clinical relevance of the SNP 
may also be further studied by examining whether carriers of 
the 3111C allele respond differently to mood stabilizers that are 
known to induce changes in circadian rhythm phase and period. 
These results directly help to further characterize the functional 
implications of this clinically relevant SNP, and because the 
3111T/C SNP is only one polymorphism of many identified for 
the CLOCK gene that associates with BD, they provide a stepping 
off point for future SNP studies in this model.
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